Platform Technology Being News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Platform Technology Being. Real-time updates on events, politics, business and more.

Acquisition Rights Obtained for Immuno-Oncology Treatments Using CAR T Technology, Cell Therapy for Cancers NASDAQ: COEP

March 29, 2023

Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Cancers: Coeptis NASDAQ: COEP

United States Frontpagestocks Corporateads Karolinska Institutet Dave Mehalick Arnika Kathleen Wagner Evren Alici

Source: einnews.com

NASDAQ: COEP Collaborates with the University of Pittsburgh Targeting HER2-Positive Cancers. $COEP; Illegally Short Sold

February 7, 2023

$COEP is Targeting HER2-POSITIVE Cancers

United States Karolinska Institutet Jason Lohmueller Dave Mehalick Alexander Deiters Frontpagestocks Corporateads

Source: einnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Platform Technology Being News Today

Acquisition Rights Obtained for Immuno-Oncology Treatments Using CAR T Technology, Cell Therapy for Cancers NASDAQ: COEP

NASDAQ: COEP Collaborates with the University of Pittsburgh Targeting HER2-Positive Cancers. $COEP; Illegally Short Sold

Explore More Categories